Data / Federal awards / NAICS 541380 / SOCIETAL CDMO SAN DIEGO, LLC
SOCIETAL CDMO SAN DIEGO, LLC: 18 federal contract awards, $-343,251 obligated (FY2024 to FY2027)
Updated October 6, 2026. Source: USAspending.gov.
SOCIETAL CDMO SAN DIEGO, LLC (UEI YRPTVKHDL7Z5), San Diego, CA, received 18 federal prime contract awards with $-343,251 obligated in fiscal years 2024 to 2027, from 2 agencies under 3 NAICS codes. Its largest buyer is Department of Health and Human Services ($793,531) and its largest code is NAICS 541380 Testing Laboratories and Services.
The request: Every federal contract awarded under NAICS 541380, with the winner, the agency and the value. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.
- UEI
- YRPTVKHDL7Z5
- Parent organization
- RECRO PHARMA, INC.
- Location
- San Diego, CA
- Business size
- Small Business
- Contract awards
- 18
- Obligated
- $-343,251
- First action in window
- 2023-11-29
- Latest action
- 2026-08-06
Where the work is
NAICS codes, with the other winners in each.
| NAICS | Industry | Awards | Obligated |
|---|---|---|---|
| 541380 | Testing Laboratories and Services | 1 | $13,375 |
| 339112 | Surgical and Medical Instrument Manufacturing | 1 | $-4,000 |
| 325412 | Pharmaceutical Preparation Manufacturing | 16 | $-352,626 |
Buying agencies
| Agency | Awards | Obligated |
|---|---|---|
| Department of Health and Human Services | 17 | $793,531 |
| Department of Veterans Affairs | 1 | $-1,136,782 |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2024 | $805,835 |
| FY2025 | $-1,136,782 |
| FY2026 | $-12,304 |
Contract awards
All 18 awards in fiscal years 2024 to 2027.
| Award ID | Agency | Type | NAICS | What it buys | Obligated in window | Award value | Starts | Ends | Place of performance | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 75N91024F00001 | Department of Health and Human Services | Delivery Order | 325412 | METARRESTIN CGMP MANUFACTURING AND STABILITY TESTING SERVICES | $711,750 | $711,750 | May 23, 2024 | May 22, 2028 | Gainesville, GA | usaspending.gov |
| 75N95023F00001 | Department of Health and Human Services | Delivery Order | 325412 | SOCIETAL IS A SMALL BUSINESS CONCERN FOR DOSAGE FORM DEVELOPMENT, MANUFACTURE, AND STABILITY STUDIES OF NCGC72 | $565,585 | $748,487 | September 29, 2023 | May 6, 2025 | San Diego, CA | usaspending.gov |
| 75N95022F00001 | Department of Health and Human Services | Delivery Order | 325412 | THIS TASK ORDER (TO) IS TO PROVIDE DOSAGE FORM DEVELOPMENT, MANUFACTURE AND STABILITY STUDIES OF ORC-13661 FOR PHASE II CLINICAL TRIAL | $180,000 | $735,749 | September 27, 2022 | May 6, 2025 | San Diego, CA | usaspending.gov |
| 75N95021F00002 | Department of Health and Human Services | Delivery Order | 325412 | DOSAGE FORM DEVELOPMENT, MANUFACTURE, AND STABILITY STUDIES OF R-VK4-116, PERIOD OF PERFORMANCE 6/1/2021 - 5/31/2025. | $19,628 | $702,849 | June 1, 2021 | May 31, 2025 | San Diego, CA | usaspending.gov |
| 75N91024P00518 | Department of Health and Human Services | Purchase Order | 541380 | FOR PAYMENT ONLY PO. RATIFICATION OF UNAUTHORIZED COMMITMENT NUMBER 20045; IRISYS; $13,375.00;NOVEMBER 6, 2018. | $13,375 | $13,375 | June 26, 2024 | July 25, 2024 | San Diego, CA | usaspending.gov |
| 75N91023F00001 | Department of Health and Human Services | Delivery Order | 325412 | NEXT DTP-23-017, PRODUCTION OF 0.25MG OF AZATDC AND TDCYD CAPSULES | $0 | $66,182 | April 18, 2023 | August 17, 2023 | San Diego, CA | usaspending.gov |
| 75N95021F00003 | Department of Health and Human Services | Delivery Order | 325412 | DOSAGE FORM DEVELOPMENT, MANUFACTURE, AND STABILITY STUDIES OF NES-100 NASAL SPRAY | $0 | $1,992,571 | September 24, 2021 | April 29, 2025 | San Diego, CA | usaspending.gov |
| 75N91021F00062 | Department of Health and Human Services | Delivery Order | 325412 | PRODUCTION OF A CGMP BATCH OF TRIAPINE INJECTION | $-1 | $249,950 | February 22, 2021 | February 21, 2024 | San Diego, CA | usaspending.gov |
| 75N91020F00005 | Department of Health and Human Services | Delivery Order | 325412 | PRODUCTION OF VARIOUS STRENGTH OF IPDR CAPSULES FOR CLINICAL USE; POP: 05/08/2020 - 05/07/2021 | $-1,304 | $223,786 | May 8, 2020 | May 7, 2022 | San Diego, CA | usaspending.gov |
| HHSN269201800182P | Department of Health and Human Services | Purchase Order | 339112 | IRISYS LLC:1259725 [18-003692] | $-4,000 | $7,000 | January 9, 2018 | January 31, 2019 | Bethesda, MD | usaspending.gov |
| 75N90020P00016 | Department of Health and Human Services | Purchase Order | 325412 | STABILITY TEST AT TIME POINT 48 MONTHS, QC AND QA REVIEW AND REPORTS BY IRISYS LLC:1259725 [POTS: 20-000431] | $-11,000 | $0 | October 30, 2019 | October 30, 2019 | San Diego, CA | usaspending.gov |
| 75N91022F00001 | Department of Health and Human Services | Delivery Order | 325412 | AZA-TDC CAPSULES FOR USE IN CLINICAL TRIAL FOR POSSIBLE CANCER TREATMENT. THE DRUG PRODUCT (DP) WILL BE A 4 MG STRENGTH CAPSULE WHICH IS NOT | $-23,799 | $153,336 | November 19, 2021 | March 31, 2024 | San Diego, CA | usaspending.gov |
| 75N91022F00004 | Department of Health and Human Services | Delivery Order | 325412 | NEXT DTP-22-018, GMP PRODUCTION OF 40 MG Z-ENDOXIFEN (NSC 774768) CAPSULES CONTRACT/TO#DCTD-2022-1007 DEVELOPMENT & MANUFACTURE OF ORAL & TO | $-40,000 | $149,535 | June 27, 2022 | March 31, 2024 | San Diego, CA | usaspending.gov |
| 75N91022F00003 | Department of Health and Human Services | Delivery Order | 325412 | NEXT DTP-22-013, PRODUCTION OF TAK-243 INJECTABLE FOR CLINICAL USE AND STUDY THE SHELF-LIFE. CONTRACT/TO#DCTC-2022-1006, DEVELOPMENT & MANUF | $-72,000 | $620,051 | April 11, 2022 | March 31, 2024 | San Diego, CA | usaspending.gov |
| 75N91021F00107 | Department of Health and Human Services | Delivery Order | 325412 | DEVELOPMENT & MANUFACTURE OF ORAL & TOPICAL DOSAGE FORMS - NOVOBIOCIN CAPSULE PRODUCTION BASE (TASK 1) 12 MONTHS & OPTION 1 (TASK 2) A CGMP | $-85,000 | $505,500 | April 19, 2021 | March 31, 2024 | San Diego, CA | usaspending.gov |
| 75N91022F00002 | Department of Health and Human Services | Delivery Order | 325412 | PRODUCTION OF AN ENGINEERING BATCH, CGMP BATCH, DELIVERY, AND SHELF-LIFE STUDY OF AMMONIUM TETRATHIOMOLIBDATE (ATTM) CAPSULES FOR USE IN CLI | $-91,875 | $321,255 | March 8, 2022 | March 31, 2024 | San Diego, CA | usaspending.gov |
| 75N95020F00001 | Department of Health and Human Services | Delivery Order | 325412 | DOSAGE FORM DEVELOPMENT, MANUFACTURE, AND STABILITY STUDIES OF AVE-1625 (DRINABANT) | $-367,828 | $704,622 | September 23, 2020 | February 28, 2025 | San Diego, CA | usaspending.gov |
| 36C24E23N0099 | Department of Veterans Affairs | Delivery Order | 325412 | PLACEBO & ACTIVE IMIQUIMOD | $-1,136,782 | $0 | May 1, 2023 | March 31, 2024 | Pittsburgh, PA | usaspending.gov |
Also on SpecStream
- All recipients under NAICS 541380 Testing Laboratories and Services
- All recipients under NAICS 339112 Surgical and Medical Instrument Manufacturing
- All recipients under NAICS 325412 Pharmaceutical Preparation Manufacturing
- Open opportunities under NAICS 541380
- Open opportunities under NAICS 339112
- Open opportunities under NAICS 325412
Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.